Introduction
============

One of the oldest dreams of the human species is the dream of a long and healthy life. In search of the "fountain of youth," diverse strategies for interventions into aging processes have been suggested. Among others, these are regular exercise and different types of diets. For instance, caloric restriction is well known in different species to lead to longevity and better health in old age ([@B23]). Another one is a mediterranean type of diet rich in fruits, vegetables, and olive oil ([@B17]; [@B69]; [@B5]).

A main goal of current aging research is to identify specific active components in complex diets and to elucidate the mechanisms by which they lead to healthy aging. As part of this goal, components of nutrients, which are considered to promote healthy life, are investigated. Polyphenols are such substances, which represent one of the largest and ubiquitous groups of secondary metabolites found in fruits and vegetables. With more than 6000 known members, flavonoids are the largest subgroup of polyphenols ([@B48]). It is known that flavonoids are excellent scavengers of reactive oxygen species (ROS) ([@B10]). Apart from this function as antioxidants, flavonoids can also act as pro-oxidants at least under some circumstances as in the presence of a high concentrations of free transition metal ions ([@B12]; [@B20]; [@B18]; [@B35]) or high doses of flavonoids ([@B77]; [@B72]). In general, flavonoids affect the abundance of ROS, molecules that, in low abundance, are essential for cell signaling to control healthy development. At high concentrations, due to their reactivity, ROS lead to damage of all kinds of cellular components and to degenerative processes like disease and aging. Such negative effects of ROS have been conceptualized in the "free radical theory of aging" (FRAT) and the "mitochondrial free radical theory of aging" (MFRAT) ([@B28], [@B29]). These theories paved the road for aging research for decades. For instance, an increased ROS scavenging was found to increase organismic lifespan of *Drosophila melanogaster* ([@B3]; [@B65]), *Caenorhabditis elegans* ([@B42]), *Podospora anserina* ([@B80]), and to increase chronological lifespan of *Saccharomyces cerevisiae* ([@B30]).

A link between the anti-oxidative capacity, aging, and lifespan control was also demonstrated in studies with quercetin, the major representative of flavonoids. In studies with different model systems, a ROS scavenging potential of quercetin was observed ([@B33], [@B34]; [@B53]). For instance, the anti-oxidative capacity of quercetin can be linked to lifespan extension in *C. elegans*, *S. cerevisiae*, and *D. melanogaster* ([@B6]; [@B34]; [@B60]; [@B56]). Furthermore, [@B54] first reported an increased longevity in human cell cultures by quercetin treatment. Beside the anti-oxidative capacity, studies with cell cultures and rats identified a pro-oxidative effect of quercetin ([@B43]; [@B50]; [@B59]). *In vitro* studies demonstrated that the anti-oxidative as well as the pro-oxidative function of quercetin is attributed to the characteristic catechol group containing two vicinal hydroxyl residues (3′- or 4′-hydroxyl residues) ([@B31]). *O*-Methylation (from now on termed methylation) of these residues can prevent both functions ([@B13]; [@B44]; [@B21]). In humans and rodents, it was shown that this kind of methylation is catalyzed by catechol-*O*-methyltransferases, a specific group of *O*-methyltransferases ([@B78], [@B79]; [@B16]).

Also in *P. anserina*, an aging model with a short lifespan that is accessible to genetic and molecular manipulation ([@B63]; [@B74]) a protein, which accumulates during aging in total protein extracts, has been identified. This protein turned out to be an *O*-methyltransferase (PaMTH1) with significant homology to the catechol-*O*-methyltransferases of humans, rodents, and other species ([@B4]). *In vitro* studies revealed that flavonoids are potential substrates of PaMTH1. An activity assay with PaMTH1 recognized myricetin, quercetin, and other flavonoids with vicinal hydroxyl residues as potential substrates ([@B39]). NMR spectroscopy confirmed that PaMTH1 has the ability to methylate myricetin and that PaMTH1 is active as a dimer ([@B15]). Furthermore, *in vivo* studies revealed an age-related PaMTH1 accumulation not only in total cell extracts but also in mitochondria ([@B4]; [@B27]; [@B39]).

A connection of oxidative effects and methyltransferase function was demonstrated in *P. anserina.* Overexpression of *PaMth1* was shown to lead to a reduced protein carbonylation suggesting that the methylation of PaMTH1 substrates prevents the incomplete oxidation and thereby the formation of ROS ([@B39]). This protective role of PaMTH1 was confirmed in investigations with a *PaMth1* deletion mutant, which showed a decreased oxidative stress resistance ([@B40]). Such a link between *O*-methyltransferase activity and aging was also obtained in other organisms. For instance, in rats a link between an *O*-methyltransferase and age-related repair of damaged proteins was demonstrated ([@B64]). In humans an increase of the abundance and activity of an *O*-methyltransferase during aging was reported ([@B68]). It appears that methylation of substrates by *O*-methyltransferase is part of evolutionary conserved pathways which affect organismal aging. However, the detailed underlying mechanisms are still poorly elucidated.

In a series of recent studies, we started to investigate the impact of natural compounds on *P. anserina* aging. Among others, we studied the polyphenols gossypol ([@B70]), curcumin ([@B71]), and here we investigated quercetin. We report novel details about the impact of quercetin on lifespan in *P. anserina*. We demonstrate that quercetin supplementation leads to an increased abundance of the PaMTH1 *O*-methyltransferase and that quercetin-induced lifespan extension requires the methylation of this flavonoid by PaMTH1. Furthermore, we reveal effects on respiration and ROS levels attributed to unmethylated quercetin which are not necessary for lifespan control.

Materials and Methods {#s1}
=====================

*P. anserina* Strains and Cultivation
-------------------------------------

In this study, the *P. anserina* wild-type (WT) strain "s" ([@B58]) and the previously generated strains *ΔPaMth1* ([@B40]) and *PaMth1_OEx* ([@B39]) were used. All transgenic strains are in the genetic background of the WT strain "s." Strains were grown on standard cornmeal agar (BMM) at 27°C under constant light ([@B55]). For spore germination, standard cornmeal agar (BMM) with 60 mM ammonium acetate was used and incubated at 27°C in the dark for 2 days (d). All strains of this study were derived from monokaryotic ascospores ([@B55]).

Quercetin and Isorhamnetin Supplementation
------------------------------------------

After spore germination, all subsequent cultivating steps were performed on M2 medium ([@B55]) with a supplementation by 300 μM of quercetin (Sigma, Q4951) or 300 μM isorhamnetin (Roth, 6528.1). Additionally, as a control, M2 medium was supplemented with 0.15% dimethylsulfoxide (DMSO; Roth, 4720.1).

Growth Rate and Lifespan Determination
--------------------------------------

Determination of the lifespan and the growth rate of *P. anserina* cultures derived from monokaryotic ascospores were performed on M2 medium with or without supplements at 27°C and constant light as previously described ([@B55]). The lifespan of *P. anserina* is defined as the time period in days (d) of linear hyphal growth while the growth rate is defined as the measured growth (cm) per time period (d).

Isolation of Mitochondria
-------------------------

*P. anserina* strains were grown on cellophane foil covered solid M2 medium containing different supplements for 2 d at 27°C and constant light. Mycelial pieces were transferred to CM-liquid medium containing different supplements and grown at 27°C and constant light for additional 2 d. Mitochondria of *P. anserina* cultures was isolated as previously described by differential centrifugation for measurement of mitochondrial oxygen consumption and by discontinuous sucrose gradient (20--36--50%) ultracentrifugation for blue-native polyacrylamide gels (BN-PAGE) analysis ([@B55]).

Mitochondrial Oxygen Consumption
--------------------------------

Determination of mitochondrial oxygen consumption was performed at 27°C by high-resolution respirometry (Oxygraph-2k series C and G, OROBOROS Instruments, Innsbruck, Austria). 200 μg freshly prepared mitochondria was injected into 2 ml air saturated oxygen buffer (0.3 M sucrose, 10 mM KH~2~PO~4~, 5 mM MgCl~2~, 1 mM EDTA, 10 mM KCl, and 0.1% BSA; pH 7.2). To promote the ADP-limited complex I-dependent state 4 respiration (state 4) 10 mM pyruvate (Sigma-Aldrich, P2256) and 2 mM malate (Sigma-Aldrich, M1000) were added. Subsequently, 1.5 mM ADP (Sigma-Aldrich, A5285) was added to determine complex I-dependent state 3 respiration (state 3). Data were analyzed using the manufacturer's software DatLab 6.

Blue-Native Polyacrylamide Gels (BN-PAGE)
-----------------------------------------

Blue-native polyacrylamide gels was performed as previously described ([@B76]). For sample preparation, 100 μg of mitochondrial protein extracts were solubilized using a digitonin (Sigma-Aldrich, D141) protein ratio of 3:1 (w/w). Linear gradient gels (4--13%) overlaid with 3.5% stacking gels were used for separation of the solubilized mitochondrial protein extracts. Respiratory chain components were visualized by Coomassie blue staining and assigned as described previously ([@B38]).

Determination of Superoxide Release
-----------------------------------

Qualitative determination of superoxide release from mycelia was performed by monitoring the reduction of nitroblue tetrazolium (NBT, Sigma-Aldrich, N6876) using a modified protocol of [@B52]. Briefly, *P. anserina* strains were cultivated for 4 d on M2 agar medium with the different supplements in the dark at 27°C. The plates were floated with 5 ml staining solution for superoxide (contains 5 mM MOPS pH 7.6, 2.5 mM NBT) and incubated for 30 min in the dark at 27°C. The solution was decanted, the plates were incubated for additional 3 h in the dark, and at 27°C to obtain the desired staining intensity.

Hydrogen Peroxide Release Measurements
--------------------------------------

Qualitative determination of hydrogen peroxide release from mycelia was performed by monitoring the oxidation of diaminobenzidine (DAB, Sigma-Aldrich, D-8001) according to a modified protocol of [@B52]. *P. anserina* strains were cultivated for 4 d on M2 agar medium with the different supplements in the dark and 27°C. The plates were floated with 5 ml staining solution for hydrogen peroxide (contains 100 mM Tris/HCl pH 6.9, 2.5 mM DAB; dissolved at 60°C for 10 min) and incubated for 30 min in the dark and 27°C. The solution was decanted, the plates were incubated for additional 3 h in the dark, and 27°C to obtain the desired staining intensity. Quantitative measurement of hydrogen peroxide was performed as previously described ([@B37]).

Isolation of Total Protein Extract
----------------------------------

Isolation of total protein extract was performed as previously described ([@B55]). Like for mitochondria isolation, appropriate supplements were added to M2 agar and to CM-liquid media.

"In-Gel" SOD Activity Assay
---------------------------

"In-gel" SOD activity assays were performed as described ([@B55]).

"In-Gel" Peroxidase and Catalase Activity Assay
-----------------------------------------------

"In-gel" peroxidase and catalase activity assays were performed as described in a previously published protocol ([@B73]).

Western Blot Analysis
---------------------

Separation of 100 μg total protein extract by SDS--PAGE and following transfer of proteins to PVDF membranes (Immobilon-FL, Millipore) was performed according to standard protocols ([@B36]). Blocking and antibody incubation of blotted PVDF membranes were performed in accordance to the Odyssey "Western Blot Analysis" handbook (LI-COR). Primary antibodies were raised against a PaSOD2-specific synthetic peptide (\[Ac\]-CERFLGTSEATKL\[OH\]; New England Peptide; 1:2000 dilution) corresponding to AA 225--236 and against a PaMTH1-specific synthetic peptide (PFNEETADRVSAYC-KLH; Sigma; 1:2000 dilution with total protein extract and 1:1000 dilution with mitochondrial protein extract). Additionally, following commercial available antibodies were used: a polyclonal rat MnSOD antibody (Biomal Stressgen, SOD-111, dilution: 1:2000) was used to detect *P. anserina* mitochondrial superoxide dismutase (SOD) (PaSOD3) and a polyclonal Cu/ZnSOD antibody (Biomol Stressgen, SOD-100; 1:2000 dilution) was used for detection of the cytoplasmic SOD (PaSOD1). Subsequently, secondary antibodies with the infrared dye IR Dye 800 (dilution: 1:15,000, Li-COR Biosciences) or IR Dye 680 LT (dilution: 1:20,000, Li-COR Biosciences) were used. For detection and densitometric quantification, the "Odyssey Infrared Imaging System" (Li-COR Biosciences) was used.

Statistical Analysis
--------------------

For statistical analysis of lifespans, the IBM SPSS statistics 19 software package was used and Kaplan--Meier survival estimates generated. Significances were determined with pairwise comparison with three independent statistical tests \[Breslow (generalized Wilcoxon), Log Rank (Mantel--Cox), and the Tarone--Ware\]. In the figure legends only the *P*-value calculated with the Breslow test is given, all other values are in the supplements (Supplementary Table [S1](#SM1){ref-type="supplementary-material"}). For all other statistical analysis, the two-tailed Student's *t*-test was used. The minimum level of statistical significance was set at *P* ≤ 0.05. ^∗^*P* ≤ 0.05, ^∗∗^*P* ≤ 0.01, ^∗∗∗^*P* ≤ 0.001.

Results
=======

Quercetin Leads to an Increased Lifespan of *P. anserina*
---------------------------------------------------------

During the course of investigations to elucidate the mechanistic effects of natural compounds on organismal aging and lifespan control, we focused our interest on the polyphenol quercetin. We used the fungal aging model *P. anserina* ([@B63]) which is a good model system for these kind of studies ([@B71]; [@B70]). First, we analyzed the effect of increasing quercetin concentrations on the growth rate of the fungus and found a concentration-dependent growth rate decrease. A concentration of 5 mM was found to reduce the growth rate by 50% whereas 300 μM lead to a 10% decrease (**Figure [1A](#F1){ref-type="fig"}**). These results demonstrate that exogenous quercetin is taken up by *P. anserina* filamentous cells (hyphae) and that the effects of the polyphenol are concentration dependent.

![Lifespan of *P. anserina* WT is increased by quercetin treatment. **(A)** Growth rate of *P. anserina* WT strains on M2 medium containing increasing concentrations of quercetin as indicated (*n* = 10 for each concentration). **(B)** Survival curve of *P. anserina* WT cultures grown on standard M2 medium containing the solvent DMSO as control (Con; total *n* = 45) or quercetin (Quer; total *n* = 46; *P* = 0.00085). **(C)** The mean lifespan and **(D)** the mean growth rates of *P. anserina* WT cultures treated with quercetin are shown as relative values to the DMSO control. Error bars correspond to the standard deviation. The *P*-values of the survival curves were determined by SPSS with three different tests and for mean lifespan and growth rate by two-tailed Student's *t*-test. ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001.](fgene-09-00160-g001){#F1}

Next, we investigated the effect of quercetin on lifespan in some more detail. We choose 300 μM quercetin and as control medium containing 0.15% of the solvent DMSO, a concentration that was also used in all further investigations. Under these conditions, quercetin moderately affects growth while DMSO does neither influences lifespan nor the growth rate (Supplementary Figures [S1A](#SM1){ref-type="supplementary-material"}--[C](#SM1){ref-type="supplementary-material"}). Treatment of the *P. anserina* WT resulted in a mean lifespan increase of 10.2% (21 d vs. 19 d) and a maximal lifespan extension of 16.6% (28 d vs. 24 d) (**Figures [1B,C](#F1){ref-type="fig"}** and Supplementary Figure [S2A](#SM1){ref-type="supplementary-material"}). As expected, the growth rate is only slightly reduced (**Figure [1D](#F1){ref-type="fig"}** and Supplementary Figure [S2B](#SM1){ref-type="supplementary-material"}).

Mitochondrial Respiration and Respiratory Complexes Are Increased by Quercetin
------------------------------------------------------------------------------

Since a link between lifespan, mitochondrial function, and quality control in *P. anserina* and other fungi is well documented ([@B24]; [@B62]; [@B1]; [@B41]; [@B22]) and since we found that other polyphenols (i.e., curcumin and gossypol) affect mitochondrial respiration in *P. anserina* ([@B71]; [@B70]), we next analyzed the effect of quercetin on mitochondrial function. First, we measured the oxygen consumption rate (OCR) of isolated mitochondria by high-resolution respirometry. The complex I-dependent OCR was determined using mitochondria isolated from WT cultures treated with quercetin and DMSO, respectively. Compared to the DMSO control, quercetin significantly increased both state 4 (ADP-limiting conditions) and state 3 OCR (addition of ADP) (**Figure [2A](#F2){ref-type="fig"}**).

![Quercetin increases respiration and the abundance of respiratory supercomplexes in the *P. anserina* WT. **(A)** Complex I-dependent oxygen consumption rate (OCR) of mitochondria from WT cultures treated with quercetin (Quer, *n* = 4 biological replicates, each with four to seven technical replicates) compared to mitochondria from cultures treated with DMSO (Con; *n* = 4 biological replicates, each with three to five technical replicates). State 4 OCR of DMSO-treated mitochondria is set to 100%. **(B)** Representative BN-PAGE analysis of isolated mitochondria from WT cultures treated with quercetin (Quer) compared to DMSO (Con)-treated cultures (*n* = 3 biological replicates for each treatment). The CI~1~CIII~2~CIV~0-2~ (S~0-2~) supercomplexes, dimeric complexes III and V (III~2~ and V~2~) as well as monomeric complexes I~1~, IV~1~, and V~1~ were visualized by Coomassie staining. **(C)** Densitometric quantification of relative protein levels of ETC complexes and supercomplexes in mitochondrial extracts from quercetin-treated cultures compared to DMSO-treated cultures. Optical densities of the different complexes were normalized to the total Coomassie staining of the corresponding lane. The mean abundance in the DMSO control was set to 1. Error bars correspond to standard deviation. The *P*-values were determined by two-tailed Student's *t*-test. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001.](fgene-09-00160-g002){#F2}

An increased respiration often results from the increased abundance of mitochondrial respiratory supercomplexes (mtRSCs) ([@B61]; [@B8]; [@B25]). Therefore, we next analyzed the composition of the mitochondrial respiratory chain by BN-PAGE analysis and found changes. In particular, quercetin supplementation increased the abundance of the mtRSCs S~1~ and S~2~ and reduced the abundance of the mtRSC S~0~ and of monomeric complexes I and IV (**Figures [2B,C](#F2){ref-type="fig"}**).

Superoxide Anion Release Is Increased by Quercetin
--------------------------------------------------

The catechol group of quercetin contains two vicinal hydroxyl residues, which can lead to ROS production ([@B35]). In addition, an altered respiration should also affect ROS production. Therefore, we next analyzed the production and detoxification of ROS, respectively. First, we histochemically measured the release of superoxide anions and hydrogen peroxide ([@B52]) from WT cultures treated with DMSO and quercetin. Changes in the release of the superoxide anion and of hydrogen peroxide by *P. anserina* cultures are indirect measures of the ROS level in different cellular compartments including the cytoplasm and mitochondria. We observed an increase in superoxide anion (increased precipitate specifically at the growth front) and a decrease in hydrogen peroxide release (slight decrease of precipitate in the whole colony) (**Figure [3A](#F3){ref-type="fig"}**). The hydrogen peroxide release was subsequently confirmed by a quantitative photometric analysis. Consistently, we observed a significant decrease of hydrogen peroxide in cultures treated with quercetin compared to DMSO (**Figure [3B](#F3){ref-type="fig"}**).

![ROS metabolism of the *P. anserina* WT is affected by quercetin. **(A)** Qualitative determination of superoxide anion release by a histochemical NBT staining and hydrogen peroxide release by a histochemical DAB staining in *P. anserina* WT cultures (*n* = 4) treated with quercetin (Quer) or DMSO (Con). **(B)** Quantitative measurement of H~2~O~2~ release from *P. anserina* WT cultures treated with quercetin (Quer; *n* = 5) compared with DMSO (Con; *n* = 5) treatment. The mean release of the DMSO-treated WT was set to 1. Error bars correspond to the standard deviation and *P*-value was determined by two-tailed Student's *t*-test. ^∗∗^*P* \< 0.01. **(C)** Representative "in-gel" superoxide dismutase (SOD) (PaSOD1 and PaSOD2) activity staining from total protein extract of *P. anserina* WT cultures treated with quercetin (Quer; *n* = 4) or DMSO (Con; *n* = 4). **(D)** Representative "in-gel" SOD (PaSOD3) activity staining from mitochondrial protein extract of *P. anserina* WT cultures treated with quercetin (Quer; *n* = 3) or DMSO (Con; *n* = 3). **(E)** Representative "in-gel" peroxidase and **(F)** catalase activity staining from total protein extracts of *P. anserina* WT cultures treated with quercetin (Quer; *n* = 4) or DMSO (Con; *n* = 4).](fgene-09-00160-g003){#F3}

The observed increase in superoxide anion release may be caused by an increased production or a reduced detoxification of superoxide anions. Accordingly, we analyzed the activity of superoxide anion and hydrogen peroxide converting enzymes, respectively. Activity of the three known SOD isoforms of *P. anserina* was investigated by "in-gel" staining. Compared to the DMSO control, we found a strong decrease in cytosolic PaSOD1 activity in quercetin-treated WT cultures (**Figure [3C](#F3){ref-type="fig"}**). The activity of the secreted PaSOD2 ([@B81]) (**Figure [3C](#F3){ref-type="fig"}**) and of the mitochondrial PaSOD3 ([@B81]) (**Figure [3D](#F3){ref-type="fig"}**) did not change. Consistent with previous findings showing that PaSOD1, PaSOD2, and PaSOD3 are regulated post-translationally ([@B9]; [@B75]), we found no significant differences in the protein amount of all three isoforms upon quercetin treatment (Supplementary Figure [S3](#SM1){ref-type="supplementary-material"}). In addition, compared to the DMSO control, the activity of the hydrogen peroxide scavenging enzyme peroxidase was reduced after quercetin treatment (**Figure [3E](#F3){ref-type="fig"}**), whereas the activity of catalases, another class of hydrogen peroxide scavenging enzymes, was not affected (**Figure [3F](#F3){ref-type="fig"}**). Overall, these data indicate that the ROS detoxification system is impaired by quercetin treatment what certainly contributes to an increased superoxide anion abundance in the *P. anserina* WT.

The PaMTH1 Level in *P. anserina* Is Increased by Quercetin
-----------------------------------------------------------

Since it is known that methylation of vicinal hydroxyl groups from polyphenols affects the generation of ROS ([@B13]; [@B44]; [@B21]; [@B35]) and since previous "*in vitro*" studies revealed that quercetin is a potential substrate of the PaMTH1 *O*-methyltransferase ([@B39]), we next analyzed whether quercetin impacts the abundance of PaMTH1. Indeed, compared to the DMSO control, we found a 1.6-fold increase of the PaMTH1 abundance in total protein extract of the WT upon quercetin treatment (**Figures [4A,B](#F4){ref-type="fig"}**). Moreover, previous studies demonstrated an increased abundance and a translocation of PaMTH1 from the cytosol to mitochondria during aging ([@B4]; [@B27]; [@B39]). Therefore, we analyzed the abundance of PaMTH1 in mitochondrial protein extracts from quercetin-treated WT cultures. Compared to the DMSO control, we found a 3.2-fold increase in mitochondria of treated cultures (**Figures [4C,D](#F4){ref-type="fig"}**). These results indicate that quercetin stimulates the PaMTH1 and its translocation into mitochondria.

![Total methyltransferase level is increased by quercetin treatment in the *P. anserina* WT. **(A)** Representative western blot analysis of total protein extract of *P. anserina* WT cultures treated with DMSO (Con; *n* = 10 biological replicates) and quercetin (Quer; *n* = 10 biological replicates), respectively. **(B)** Quantification of PaMTH1 protein level normalized to the Coomassie-stained gel. Protein level in the DMSO control was set to 1. **(C)** Representative western blot analysis of mitochondrial protein extract of *P. anserina* WT cultures treated with DMSO (Con; *n* = 6 biological replicates) or quercetin (Quer; *n* = 6 biological replicates). **(D)** Quantification of PaMTH1 protein abundance normalized to the Coomassie-stained gel. Protein level in the DMSO control was set to 1. Error bars correspond to the standard deviation and *P*-values were determined by two-tailed Student's *t*-test. ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001.](fgene-09-00160-g004){#F4}

PaMTH1 Is Required for Quercetin-Induced Longevity
--------------------------------------------------

The quercetin-induced increase of PaMTH1 abundance suggests a role of PaMTH1 in quercetin-induced longevity. To address this possibility experimentally, we investigated the effect of quercetin in a *PaMth1* deletion mutant (*ΔPaMth1*) and a *PaMth1* overexpression strain (*PaMth1_OEx*). First, we determined the lifespan of both mutants. Strikingly, in comparison to the WT (**Figure [1B](#F1){ref-type="fig"}**), the lifespan of *ΔPaMth1* is not affected by quercetin treatment (**Figure [5A](#F5){ref-type="fig"}**). Most interestingly, the mean lifespan increasing effect of quercetin in the WT (**Figure [1C](#F1){ref-type="fig"}**) is not observed in the deletion mutant (**Figure [5B](#F5){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**, and Supplementary Figure [S2C](#SM1){ref-type="supplementary-material"}). Also, this mutant exhibited no difference in relative growth rate upon quercetin treatment (**Figure [5C](#F5){ref-type="fig"}** and Supplementary Figure [S2D](#SM1){ref-type="supplementary-material"}). In contrast, in *PaMth1* overexpressing strains lifespan is increased by quercetin (**Figure [5D](#F5){ref-type="fig"}**). Interestingly, quercetin has a significantly stronger effect on mean lifespan of *PaMth1_OEx* than in the WT. In the overexpression mutant, the relative mean lifespan is increased by 13.4% (23 d vs. 20 d) (**Figure [5E](#F5){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**, and Supplementary Figure [S2E](#SM1){ref-type="supplementary-material"}), while an increase of only 10.2% is observed in the WT (**Figure [1C](#F1){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**). As in the WT, the growth rate of the *PaMth1* overexpression mutant is slightly reduced (**Figure [5F](#F5){ref-type="fig"}** and Supplementary Figure [S2F](#SM1){ref-type="supplementary-material"}). Compared to the WT treated with quercetin we found a stronger increase in the amount of PaMTH1 in the overexpression mutant (**Figures [5G,H](#F5){ref-type="fig"}**). Therefore, we assume that in the *PaMth1* overexpression mutant quercetin methylation is higher than the WT suggesting that the level of quercetin methylation regulated lifespan extension.

![Lifespan extension by quercetin is dependent of *O*-methyltransferase activity. **(A)** Lifespan of *ΔPaMth1* cultures grown on standard M2 medium containing DMSO (Con; *n* = 34) or quercetin (Quer; *n* = 31; *P* = 0.13878). **(B)** Relative mean lifespan of cultures from **(A)**. Data shown as relative values compared to the DMSO control, which was set to 100%, ±standard derivation. **(C)** Relative mean growth rate of cultures from **(A)**. Data shown as relative values compared to the DMSO control, which was set to 100%, ±standard derivation. **(D)** Lifespan of *P. anserina Mth1_OEx* cultures grown on standard M2 medium containing DMSO (Con; *n* = 25) or quercetin (Quer; *n* = 25; *P* = 0.00012). **(E)** Relative mean lifespan of cultures from **(D)**. Data are shown as relative values compared to the DMSO control, which was set to 100%, ±standard derivation. **(F)** Relative mean growth rate of cultures from **(D)**. Data are indicated as relative values compared to the DMSO control, which was set to 100%, ±standard derivation. **(G)** Representative western blot analysis of total protein extract of *P. anserina* WT (*n* = 4) and *PaMth1_OEx* cultures (OEx; *n* = 4) treated with DMSO (Con) or quercetin (Quer). **(H)** Quantification of PaMTH1 protein level normalized to the Coomassie-stained gel. Protein level in WT cultures treated with DMSO was set to 1. Error bars correspond to the standard deviation and *P*-values were determined by two-tailed Student's *t*-test. ^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001.](fgene-09-00160-g005){#F5}

###### 

Overview about the relative change in mean lifespan by quercetin and isorhamnetin in different *P. anserina* strains.

                 Quercetin                Isorhamnetin
  -------------- ------------------------ ------------------------
  Wild type      +10.2% (21 d vs. 19 d)   +17.5% (23 d vs. 20 d)
  Δ*PaMth1*      +4.9% (20 d vs. 19 d)    +13.5% (24 d vs. 21 d)
  *PaMth1_OEx*   +13.4% (23 d vs. 20 d)   

Overall, our data suggest that PaMTH1 is required for quercetin-induced lifespan extension and provides new mechanistic support of earlier findings about a role of PaMTH1 in lifespan control ([@B39], [@B40]; [@B15]).

PaMTH1 Affects Mitochondrial Respiration and ROS Abundance
----------------------------------------------------------

To experimentally analyze the impact of quercetin and PaMTH1 on aging and lifespan control in some more detail, we next investigated the effect of the methylation of quercetin on respiration in *PaMth1* mutants. Unexpectedly, we found that, in comparison to the WT, quercetin treatment leads to a higher increase of the OCR in both analyzed respiration states in the *PaMth1* deletion mutant (**Figure [6A](#F6){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**). In concordance, the OCR of the overexpression mutant is less affected compared to the WT (**Figure [6B](#F6){ref-type="fig"}** and **Table [2](#T2){ref-type="table"}**).

![Mitochondrial function and ROS metabolism are affected depending on the methylation state of quercetin. **(A)** Complex I-dependent OCR of mitochondria from *ΔPaMth1* cultures treated with quercetin (Quer, *n* = 3 biological replicates, each with six technical replicates) compared to mitochondria from cultures treated with DMSO (Con; *n* = 3 biological replicates, each with five technical replicates). State 4 OCR of DMSO-treated mitochondria was set to 100%. **(B)** Complex I-dependent OCR of mitochondria from *PaMth1_OEx* cultures treated with quercetin (Quer, *n* = 3 biological replicates, each with five to six technical replicates) compared to mitochondria from cultures treated with DMSO (Con; *n* = 3 biological replicates, each with five technical replicates). State 4 OCR of DMSO-treated mitochondria was set to 100%. **(C)** Qualitative determination of superoxide anion release by a histochemical NBT staining and hydrogen peroxide release by a histochemical DAB staining in *ΔPaMth1* and *PaMth1_OEx* cultures (*n* = 4) treated with quercetin (Quer) or DMSO (Con). **(D)** Quantification of H~2~O~2~ release measurement from *P. anserina ΔPaMth1* cultures treated with quercetin (Quer; *n* = 4) compared to DMSO (Con; *n* = 4) treatment. The mean release of the DMSO-treated cultures was set to 1. **(E)** Quantification of H~2~O~2~ release measurement from *P. anserina PaMth1_OEx* cultures treated with quercetin (Quer; *n* = 4) compared to DMSO (Con; *n* = 4) treatment. The mean release of the DMSO-treated cultures was set to 1. **(F)** Representative "in-gel" SOD (PaSOD1 and PaSOD2) activity staining and **(G)** "in-gel" peroxidase activity staining from total protein extract of *ΔPaMth1* and *PaMth1_OEx* cultures treated with quercetin (Quer; *n* = 4) or DMSO (Con; *n* = 4). Error bars correspond to the standard deviation and *P*-values were determined by two-tailed Student's *t*-test. ^∗^*P* \< 0.05, ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001.](fgene-09-00160-g006){#F6}

###### 

Overview about the relative changes in the respiration states of *P. anserina* WT and mutants with the different supplementations compared to the respective DMSO control.

                 Quercetin (%)   Isorhamnetin (%)         
  -------------- --------------- ------------------ ----- ----
  Wild type      +47             +41                +30   +7
  Δ*PaMth1*      +83             +93                      
  *PaMth1_OEx*   +40             +29                      

Next, we analyzed whether or not ROS levels are influenced by the methylation of quercetin. We histochemically examined the superoxide anion and hydrogen peroxid release of both *PaMth1* mutants. Compared to the WT we found a higher release of superoxide anions in the deletion mutant. In the overexpression mutant the release is hardly affected (**Figure [6C](#F6){ref-type="fig"}**). In contrast, hydrogen peroxide is lowered in the *PaMth1* deletion strain and rather unaffected in the overexpression strain (**Figure [6C](#F6){ref-type="fig"}**). We quantified hydrogen peroxid release and observed a significant lower release in the deletion mutant and no change in the overexpression strain (**Figures [6D,E](#F6){ref-type="fig"}**) suggesting a methylation-dependent effect of quercetin on the activity of the superoxide scavenging enzyme PaSOD1. This conclusion is supported by a strongly decreased PaSOD1 activity in *ΔPaMth1*, and a slightly reduced activity in *PaMth1_OEx* after quercetin treatment (**Figure [6F](#F6){ref-type="fig"}**). Like in the WT, these activity changes do not result from differences in the amount of PaSOD1 but rather from post-translational activation (Supplementary Figure [S4](#SM1){ref-type="supplementary-material"}). The lowered hydrogen peroxide release seems to affect the activity of the hydrogen peroxide scavenging peroxidase. Quercetin treatment leads to a strongly reduced peroxidase activity in *ΔPaMth1* and a slight decrease in *PaMth1_OEx* (**Figure [6G](#F6){ref-type="fig"}**).

Isorhamnetin Increases the Lifespan of *P. anserina*
----------------------------------------------------

To confirm the impact of methylation of quercetin on aging and lifespan control we next investigated the impact of isorhamnetin, a methylated metabolite of quercetin, on the lifespan of *P. anserina*. Compared to quercetin the amount of PaMTH1 is not affected by isorhamnetin (**Figures [7A,B](#F7){ref-type="fig"}**). Similar to quercetin (**Figure [1B](#F1){ref-type="fig"}**), isorhamnetin increases the lifespan of the WT (**Figure [7C](#F7){ref-type="fig"}**). Compared to the DMSO control, the mean lifespan is significantly increased by 17.5% (23 d vs. 20 d; **Figure [7D](#F7){ref-type="fig"}** and Supplementary Figure [S5A](#SM1){ref-type="supplementary-material"}). Strikingly, this mean lifespan increase is significantly more pronounced by treatment with isorhamnetin (+17.5%) than with quercetin (+10.2%; **Table [1](#T1){ref-type="table"}**) suggesting that lifespan extension is dependent on the methylation state of quercetin. This is confirmed by data obtained from the *PaMth1* deletion mutant. Unlike quercetin, for which methylation depends on endogenous PaMTH1, isorhamnetin is independent of this enzyme. Consistently, lifespan increase is observed in the absence of the enzyme (**Figure [7E](#F7){ref-type="fig"}**). Compared to the DMSO control, the mean lifespan is increased by 13.5% (24 d vs. 21 d) (**Figure [7F](#F7){ref-type="fig"}**, **Table [1](#T1){ref-type="table"}**, and Supplementary Figure [S5B](#SM1){ref-type="supplementary-material"}).

![Isorhamnetin increases lifespan of the WT and *PaMth1* deletion mutant. **(A)** Representative western blot analysis of total protein extract of *P. anserina* WT cultures treated with DMSO (Con; *n* = 4) and isorhamnetin (Isor; *n* = 4), respectively. **(B)** Quantification of PaMTH1 protein level normalized to the Coomassie-stained gel. Protein level in the DMSO control was set to 1. Protein level in the DMSO control was set to 1. **(C)** Lifespan of *P. anserina* WT cultures grown on standard M2 medium containing DMSO (Con; total *n* = 15) or isorhamnetin (Isor; total *n* = 15; *P* = 0.00016). **(D)** Lifespan of *ΔPaMth1* cultures grown on standard M2 medium containing DMSO (Con; total *n* = 15) or isorhamnetin (Isor; total *n* = 15; *P* = 0.00045). **(E)** Relative mean lifespan of cultures from **(A)**. Data shown as relative values compared to the DMSO control, which was set to 100%. **(F)** Relative mean lifespan of cultures from **(B)**. Data shown as relative values compared to the DMSO control, which was set to 100%. Error bars correspond to the standard deviation and *P*-values of the survival curves were determined by SPSS with three different tests and for mean lifespan by two-tailed Student's *t*-test. ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001.](fgene-09-00160-g007){#F7}

Next, we analyzed the impact of isorhamnetin on respiration, the respiratory chain, and ROS abundance. Treatment with isorhamnetin did not show any effect on complex I-dependent OCR of WT mitochondria (**Figure [8A](#F8){ref-type="fig"}**). This unchanged respiration suggested that the composition of the respiratory chain is unchanged as well. Indeed, isorhamnetin did not change the composition of the respiratory chain as seen in the BN-PAGE (**Figure [8B](#F8){ref-type="fig"}**). Quantification of protein bands revealed that the amount of respiratory chain complexes and mtRSCs was unchanged (**Figure [8C](#F8){ref-type="fig"}**). Also, the analysis of the ROS metabolism provides no differences in strains treated with isorhamnetin or DMSO. In detail, the release of superoxide anions and hydrogen peroxide (**Figures [8D,E](#F8){ref-type="fig"}**) as well as the activity of PaSOD1 (**Figure [8F](#F8){ref-type="fig"}**) and of peroxidase is not affected (**Figure [8G](#F8){ref-type="fig"}**). These data support the findings from investigations with the *PaMth1* mutants that methylated quercetin affects lifespan and not the OCR and the ROS abundance.

![Isorhamnetin do not affect respiration and ROS metabolism of the *P. anserina* WT. **(A)** Complex I-dependent OCR of mitochondria from WT cultures treated with isorhamnetin (Isor, *n* = 4 biological replicates, each with three to six technical replicates) compared to mitochondria from DMSO-treated cultures (Con; *n* = 3 biological replicates, each with five technical replicates). State 4 OCR of DMSO-treated mitochondria was set to 100%. **(B)** Representative BN-PAGE analysis of isolated mitochondria from WT cultures treated with isorhamnetin (Isor) compared to DMSO (Con) treated. The CI~1~CIII~2~CIV~0-2~ (S~0-2~) supercomplexes, dimeric complexes III and V (III~2~ and V~2~) as well as monomeric complexes I~1~, IV~1~, and V~1~ are visualized by Coomassie staining. **(C)** Densitometric quantification of relative protein levels of ETC complexes and supercomplexes in mitochondrial extracts from isorhamnetin-treated cultures compared to DMSO-treated cultures. Optical densities of the different complexes were normalized to the total Coomassie staining of the corresponding lane. The mean abundance in the DMSO control was set to 1. **(D)** Qualitative determination of superoxide anion and hydrogen peroxide release in *P. anserina* WT cultures (*n* = 4) treated with isorhamnetin (Isor) or DMSO (Con) by a histochemical staining protocol using NBT and DAB. **(E)** Quantification of H~2~O~2~ release measurement from *P. anserina PaMth1_OEx* cultures treated with quercetin (Quer; *n* = 4) compared to DMSO (Con; *n* = 4) treatment. The mean release of the DMSO-treated cultures was set to 1. **(F)** Representative "in-gel" SOD (PaSOD1 and PaSOD2) activity staining, **(G)** representative "in-gel" peroxidase activity staining from total protein extract of *P. anserina* WT cultures treated with isorhamnetin (Isor) or DMSO (Con).](fgene-09-00160-g008){#F8}

Discussion
==========

In our effort to unravel mechanistic insights about the role of natural compounds used to intervene into aging processes, we found that supplementation of the growth medium with 300 μM quercetin leads to an increase in mean and maximal lifespan of *P. anserina*. These data are in line with previously published findings in *C. elegans*, *S. cerevisiae*, and *D. melanogaster* ([@B6]; [@B34]; [@B60]; [@B56]). Similar to the 10% lifespan extension in *P. anserina*, [@B66] also found a lifespan extension by 10% in *C. elegans* after treatment with quercetin. Most strikingly, in *P. anserina* this effect is linked to an increased abundance of PaMTH1, an enzyme that previously was found to accumulate in total cell extracts and in mitochondria during aging ([@B4]; [@B27]; [@B39]). An *in-vitro* analysis revealed an *S*-adenosylmethionine-dependent *O*-methyltransferase activity of PaMTH1 which methylates vicinal hydroxyl groups in polyphenols like myricetin and quercetin ([@B39]; [@B15]). Overexpression of *PaMth1* leads to an increased lifespan while deletion of the gene resulted in a decreased resistance against oxidative stress and a shortened lifespan ([@B39], [@B40]).

In the current study we show for the first time that the *S*-adenosylmethionine-dependent *O*-methyltransferase PaMTH1 is required for quercetin-induced lifespan extension. Particularly, data from investigations of *PaMth1* mutants revealed a methylation-dependent quercetin effect on lifespan. Following supplementation of the growth medium with the methylated quercetin derivative isorhamnetin supports the conclusion that effects of quercetin treatment are depending on the methylation of this flavonoid. While quercetin does not affect lifespan of the *PaMth1* deletion mutant, isorhamnetin leads to lifespan extension. In the WT, isorhamnetin has a significantly greater effect than quercetin. However, although not statistically different, there is a marginal difference found in the *PaMth1* deletion mutant. We cannot completely exclude that this difference results from the activity of other *O*-methyltransferases or that unmethylated quercetin also has some minor effect on lifespan. Regardless, the PaMTH1 *O*-methyltransferase, which in a previous *in vitro* assay was shown to effectively methylate quercetin ([@B39]; [@B35]), is responsible for the observed lifespan extension of our study. Furthermore, the association of quercetin, PaMTH1, and methylation is supported by data from *C. elegans* showing that transcript-levels of two different *O*-methyltransferases are upregulated upon treatment with quercetin or the polyphenol tannic acid ([@B57]). Also, previous studies with *C. elegans* showed that methylated derivatives of quercetin or epicatechin have a more pronounced effect on lifespan than the unmethylated versions ([@B66], [@B67]). However, the *C. elegans* study did not experimentally link the effect of an *O*-methyltransferase-dependent methylation, the dietary application of quercetin and lifespan.

Apart from the methylation-dependent effects of quercetin, our study shows that not all quercetin effects are caused by methylated derivatives and linked to the lifespan-extending effect of quercetin. In particular, we found that the effect on OCR and the pro-oxidative effects, the decreased PaSOD1 activity and the increased superoxide release, are based on the unmethylated quercetin without a link to lifespan extension. In concordance with the role of *O*-methylation in the prevention of pro-oxidative effects ([@B13]; [@B44]; [@B21]), we found that isorhamnetin has no pro-oxidative capacity like quercetin. From these data we conclude that unmethylated quercetin leads to a decline of components of the cellular ROS scavenging system (e.g., PaSOD1) as seen in the WT and the *PaMth1* deletion mutant.

Despite the increase of superoxide anion release, we obtained an enhanced OCR resulting from an increase in mtRSCs upon quercetin treatment of the WT. Normally, an increase in mtRSCs is known to improve electron flow ([@B61]; [@B7], [@B8]) and thereby reduces the generation of superoxide anion ([@B45]; [@B26]; [@B49]). Hence, the increase of OCR and mtRSCs (S~1~ and S~2~) abundance is a possible kind of compensation mechanism to prevent a superoxide anion generation in addition to the generation through unmethylated hydroxyl residues of quercetin.

Our observation that methylation-dependent effects of quercetin may also apply to higher eukaryotes including humans are supported by different studies in pigs, rodents, and humans. Previous investigations revealed that after oral application of quercetin mostly methylated quercetin metabolites accumulated in blood plasma and in different organs ([@B78]; [@B46], [@B48]; [@B2]; [@B11]; [@B14]; [@B32]). For instance in humans, after oral application of quercetin, 21% of this flavonoid circulating in the plasma was present as the methylated metabolite isorhamnetin ([@B19]). In rats, this percentage (86%) was even higher ([@B51]; [@B47]). In line with our findings and with findings from other organisms, [@B54] exhibited an increased longevity in human cell cultures by quercetin treatment. In contrast to our study, this lifespan increasing effect was not linked to methylated derivative of quercetin. This role of a methyltransferase is now an important issue with perspectives for the use of quercetin in therapies to intervene into human aging. For instance, one approach could be to induce a more efficient cellular methylation capacity of quercetin via the induction of genes coding for specific *O*-methyltransferases. Another possible strategy is a direct diet with isorhamnetin, a strategy that currently is a very costly treatment. Investigations with model systems like *P. anserina* may help to unravel more mechanistic details about effective triggers in this field of research and to develop realistic interventions into aging processes.
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